iCrowd Newswire – Jul 20, 2020
Acne Medication Market size is forecast to reach $ 8.71 billion by 2025, growing at a CAGR of 4.19% during the forecast period 2020-2025. Increase in prevalence of acne among the teenagers and increasing awareness among consumers of acne treatment are the major factors driving the growth of the market. Rise in the disposable income of consumers and skin dryness owing to unhealthy lifestyle & pollution is set to further enhance the overall market demand of Acne Medication during the forecast period 2020-2025.
Type – Segment Analysis
Over The Counter Medicine held major share in the Acne Medication Market in 2019. Over the-counter acne products are available to treat mild to moderate acne or periodic breakouts. They include cleansing lotions, gels, foams and towelettes, leave-on products and treatments or kits. Active ingredients found in over the counter medicine are Benzoyl peroxide, Salicylic acid, Alpha hydroxy acids and Sulfur. Benzoyl peroxide kills the bacteria that cause acne, helps remove excess oil from the skin and removes dead skin cells, which can clog pores and are available in strengths from 2.5 to 10 percent. Salicylic acid helps prevent pores from becoming plugged and are available in strengths from 0.5 to 5 percent. Alpha hydroxy acids are synthetic versions of acids derived from sugar-containing fruits. They treat acne by helping to remove dead skin cells and reduce inflammation. Alpha hydroxy acids also stimulate the growth of new and smoother skin. This helps to improve the appearance of acne scars and gives the impression of smaller pores.
Therapeutic Class- Segment Analysis
Retinoid segment held the largest share in the Acne Medication Market in 2019 and is estimated to grow at a CAGR of 3.86% during the forecast period 2020-2025. The growth in this segment can be attributed to its class of prescription medications used to control comodonal acne (blackheads and whiteheads). Retinoid is referred to as retinoic acid or vitamin A acid. Topical retinoids are available as gels, ointments, creams or foams to be applied directly to the skin. They work by promoting the exfoliation of dead skin cells as well as by boosting the production of new skin cells. The new cells then push dead cells and excess oil out of blocked pores. Retinoids also have anti-inflammatory properties. Retinoid is estimated to be the fastest growing segment and is set to register a highest CAGR during the forecast period 2020-2025.
Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=502207
Report Price: $ 4500 (Single User License)
Geography – Segment Analysis
North America dominated the acne medication market in 2019 with a share of more than 39.71%, followed by Asia Pacific owing to growing number of people suffering from acne problem. Rise in concern for facial aesthetics in the America region is set to eventually lead to growing demand for acne medication products. Presence of better acne treatment options, increased affordability, and greater awareness regarding acne treatment along with the increasing demand of the population to spend on facial appearance is boosting the acne medication market in the North America region.
However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025. This is owing to growing awareness regarding the treatment options. Increase in disposable income, rising incidence of acne disorder, presence of options to acne treatment. Concern regarding facial beauty among the population in countries like China, India and increasing behavior of unhealthy eating patterns is driving the growth of the acne medication market in Asia Pacific region.
Drivers – Acne Medication Market
- Rise in the disposable income of consumers
Rise in the disposable income of consumers is poised to boost the growing demand of acne medication market owing to the growing demand and adoption rate of acne medication. Acne treatments are used for the treatment of moderate to severe cases of acne which can cause disfigurations. Acne is a condition which affects the oil glands in certain surfaces of the skin. Growing concern among the people regarding their physical appearance and is set to enhance the growth of acne medication market. Increasing cases of acne owing to lifestyles led by the current patients and its high prevalence among teens is driving the growth of the acne medication market.
- Increasing awareness among consumers of acne treatment
Increasing awareness among the consumers of acne treatment is set to boost the growing demand of acne medication market owing to the large cosmetic expenditure and awareness of skin conditions. Acne medication work to clear away bacteria and dry up the excess oils that lead to acne. Different acne treatments includes lifestyle remedies, topical medication, oral medication and medical procedures. Growing awareness regarding the acne treatment among the people living and people becoming more aware of the need to treat acne problems to boost the growth of the acne medication market in the forecast period 2020-2025.
Challenges – Acne Medication Market
- Side effects of acne medication and increased risk of blood clots high blood pressure
Some of the factors which is set to impede the growth of the Acne Medication market are topical acne drugs lead to skin dryness and oral medication lead to dizziness and lightheaded and also increases risk of blood clots with high blood pressure. Presence of alternative treatments such as laser therapies is also set to hamper the growth of the market.
Acne Medication Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the acne medication market. In 2019, Acne Medication Market share is consolidated by the top ten players present in the market. Acne Medication top 10 companies are Allergan Plc , Glaxosmithkline Plc , Johnson Johnson , Mayne Pharma Group Limited , Mylan N V , Nestle S A, Pfizer Inc , Sun Pharma , Teva Pharmaceutical Industry Ltd and Valeant Pharmaceutical International Inc among others
Talk to one of our sales representative about the full report by providing your details in the link below:
- Bausch Health Company has obtained approval from the FDA for their drug called ARAZALO. It is a prescription medicine that helps to treat vulgar acne.
- GSK has gained approval for the marketing of its drug Fabiour foam for the removal of pimples and black heads. This product has received U.S. F.D.A for the care of patients aged 12 years or over with mild to serious acne.
- North America dominated the Acne Medication Market in 2019 owing to the high prescription of the medicine and reduced inflammation of acne blemishes .The Acne Medication Market scope for different regions will be provided in the final report.
- Growing number of people suffering from acne problem and improvement in post inflammatory hyperpigmentation is likely to aid in the market growth of Acne Medication Market.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Acne Medication Market report.
- Side effects of acne medication and increased risk of blood clots with high blood pressure is poised to create hurdles for the Acne Medication Market.
Related Reports :
- Acne Vulgaris Market
- Anti-Acne Cosmetics Market
About IndustryARC:IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.
Email: [email protected]
Phone: (+1) 970-236-3677
Keywords: Acne Medication market, Acne Medication market size, Acne Medication industry, Acne Medication market share, Acne Medication top 10 companies, Acne Medication market report, Acne Medication industry outlook